載入...
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
Histone deacetylase inhibitors are members of a class of epigenetic drugs that have proven activity in T-cell malignancies, but little is known about their efficacy in B-cell lymphomas. Abexinostat is an orally available hydroxamate-containing histone deacetylase inhibitor that differs from approved...
Na minha lista:
| 發表在: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ferrata Storti Foundation
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477609/ https://ncbi.nlm.nih.gov/pubmed/28126962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.154377 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|